ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,064Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 300

$1.48M Total Retail Price of All Prescriptions

Rank: 4 out of 300

455 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 455 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

25% of this provider’s 455 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 17,713 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 4%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $81 among peers.

Prescriptions per Patient

53 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 1,128 714 S3 1 1
AMLODIPINE BESYLATE 997 773 2 2
LISINOPRIL 677 483 3 4
OMEPRAZOLE 642 466 4 11
POTASSIUM CHLORIDE 637 483 5 22
WARFARIN SODIUM 583 498 6 10
LEVOTHYROXINE SODIUM 511 400 7 9
HYDROCHLOROTHIAZIDE 510 405 8 20
ZOLPIDEM TARTRATE 456 325 9 21
SIMVASTATIN 442 352 10 5
METFORMIN HCL 442 271 10 19
FUROSEMIDE 379 302 12 3
CRESTOR 374 290 13 26
GABAPENTIN 374 231 13 7
TRAMADOL HCL 352 292 15 23
NEXIUM 333 231 16 17
CARVEDILOL 330 220 17 12
SERTRALINE HCL 267 191 18 41
MELOXICAM 231 169 19 27
PREDNISONE 230 187 20 33
TRAMADOL HCL-ACETAMINOPHEN 212 190 21 167
ATENOLOL 211 188 22 31
CYMBALTA 201 135 23 37
CLOPIDOGREL 193 171 24 18
SUCRALFATE 180 152 25 210
TAMSULOSIN HCL 176 147 26 8
ZETIA 175 141 27 109
METOPROLOL SUCCINATE 175 138 27 6
LEVOCETIRIZINE DIHYDROCHLORIDE 166 113 29 81
METOPROLOL TARTRATE 164 140 30 13
AZITHROMYCIN 161 99 31 72
CITALOPRAM HBR 160 118 32 54
POLYETHYLENE GLYCOL 3350 155 128 33 47
CYCLOBENZAPRINE HCL 154 84 R 34 71
DIOVAN 152 149 35 46
SINGULAIR 145 124 36 114
JANUVIA 144 127 37 100
RANITIDINE HCL 137 103 38 112
LOSARTAN POTASSIUM 136 117 39 29
PLAVIX 135 123 40 24
DIGOXIN 135 109 40 39
LYRICA 131 77 42 55
ALLOPURINOL 130 107 43 44
DEXILANT 126 95 44 119
LOVAZA 126 85 44 129
SYNTHROID 119 95 46 49
NAMENDA 119 119 46 48
ADVAIR DISKUS 117 74 48 60
NASONEX 113 61 49 158
VOLTAREN 113 99 49 232
ESCITALOPRAM OXALATE 110 64 51 78
DONEPEZIL HCL 110 101 51 57
TORSEMIDE 109 104 53 188
BYSTOLIC 106 83 54 59
MORPHINE SULFATE ER 105 32 S2 55 45
FAMOTIDINE 102 68 56 192
TRAZODONE HCL 102 76 56 65
NABUMETONE 101 75 58 159
METOCLOPRAMIDE HCL 101 59 58 139
PROMETHAZINE HCL 100 57 R 60 103
GLIMEPIRIDE 99 79 61 51
LIDODERM 97 87 62 263
ALENDRONATE SODIUM 97 71 62 61
PROAIR HFA 97 48 62 138
RAMIPRIL 93 82 65 63
ATORVASTATIN CALCIUM 93 69 65 14
CLEMASTINE FUMARATE 92 60 R 67 275
FLUTICASONE PROPIONATE 92 69 67 34
QUETIAPINE FUMARATE 92 57 67 79
MONTELUKAST SODIUM 88 70 70 198
SPIRONOLACTONE 88 48 70 92
BUSPIRONE HCL 87 62 72 215
ROPINIROLE HCL 87 62 72 121
PRAVASTATIN SODIUM 84 72 74 15
CELEBREX 84 60 74 150
NOVOLOG 83 65 76 229
FLUOXETINE HCL 82 64 77 117
ISOSORBIDE MONONITRATE ER 79 61 78 32
SPIRIVA 76 62 79 84
BENAZEPRIL HCL 76 64 79 73
HYDRALAZINE HCL 73 65 81 56
INSULIN SYRINGE 72 45 82 156
COREG CR 72 62 82 277
PRENATAL PLUS 70 55 84 385
MECLIZINE HCL 69 37 85 147
AMITRIPTYLINE HCL 68 40 R 86 66
WELCHOL 67 54 87 339
RISPERIDONE 67 32 87 116
METHOTREXATE 66 47 89 53
NIASPAN 66 44 89 183
TRICOR 65 34 91 161
CARISOPRODOL 65 21 R 91 36
LANTUS 63 39 93 125
AMIODARONE HCL 62 50 94 96
OXYCODONE HCL-ACETAMINOPHEN 62 18 S2 94 62
TRIAMTERENE-HCTZ 61 45 96 118
AMLODIPINE BESYLATE-BENAZEPRIL 61 50 96 52
LEVOFLOXACIN 60 40 98 169
FELODIPINE ER 58 50 99 276
MUPIROCIN 57 50 100 151
SULFAMETHOXAZOLE-TRIMETHOPRIM 57 47 100 70
LUNESTA 57 43 100 239
ENABLEX 55 55 103 201
LIPITOR 54 36 104 115
PRAMIPEXOLE DIHYDROCHLORIDE 53 50 105 130
ACTONEL 53 53 105 266
ACETAMINOPHEN-CODEINE 53 46 S3 105 232
FENTANYL 53 40 S2 105 95
EVISTA 52 49 109 196
FORTICAL 51 49 110 306
ACARBOSE 51 32 110 286
FLUCONAZOLE 51 31 110 224
LOVASTATIN 50 39 113 68
AMOXICILLIN 50 37 113 142
FINASTERIDE 50 50 113 24
LEVEMIR 50 46 113 353
ABILIFY 50 0 113 132
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.